FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

441864003: Degarelix (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2009. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2817699019 Degarelix en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2817700018 Degarelix (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
54371000195114 degarelix it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
804301000172115 dégarélix fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
69531000195113 Degarelix de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Degarelix Is a Gonadotropin releasing hormone receptor antagonist true Inferred relationship Some
Degarelix This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Gonadotropin releasing hormone receptor antagonist (disposition) true Inferred relationship Some
Degarelix This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Hormone receptor antagonist false Inferred relationship Some
Degarelix Is a Antihormone false Inferred relationship Some
Degarelix Is a Polypeptide true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely degarelix 80 milligram/1 vial powder for conventional release solution for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Degarelix Inferred relationship Some
Product containing degarelix (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Degarelix Inferred relationship Some 1
Product containing precisely degarelix 120 milligram/1 vial powder for conventional release solution for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Degarelix Inferred relationship Some
Product containing only degarelix (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Degarelix Inferred relationship Some 1
Product containing precisely degarelix 80 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Degarelix Inferred relationship Some 1
Product containing precisely degarelix 80 milligram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Degarelix Inferred relationship Some 1
Product containing precisely degarelix 120 milligram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Degarelix Inferred relationship Some 1
Product containing precisely degarelix 120 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Degarelix Inferred relationship Some 1
Product containing degarelix in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Degarelix Inferred relationship Some 1
Product containing only degarelix in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Degarelix Inferred relationship Some 1

This concept is not in any reference sets

Back to Start